The first batch of an experimental vaccine against Ebola is on its way to Liberia. The shipment will be the first potentially preventative medicine to reach one of the hardest hit countries.

A trial of a potential drug to treat Ebola has started at a Medecins Sans Frontieres centre in Liberia.

 The World Health Organization (WHO) says there has been a decline in the spread of Ebola in Liberia, the country hardest hit in the outbreak.

 Nurses and medical assistants fighting the Ebola outbreak in Liberia have largely ignored a call to strike over danger money and conditions.

 Liberia is facing a "serious threat" to its national existence as the deadly Ebola virus "spreads like wildfire" there, its defence minister says.

 Liberia has imposed a night-time curfew and has quarantined an area of the capital Monrovia in a bid to halt the deadly Ebola outbreak.

 Liberia will receive an untested experimental drug, Zmapp, to treat people infected with Ebola, the Liberian government says.

 Liberian President Ellen Johnson Sirleaf has declared a state of emergency as the country grapples with an outbreak of the deadly Ebola virus.

 Most border crossings in Liberia have been closed and communities hit by an Ebola outbreak face quarantine to try to halt the spread of the virus.